Improved survival after unrelated donor bone marrow transplantation in children with primary immunodeficiency using a reduced-intensity conditioning regimen.

Blood
Kanchan RaoPaul A Veys

Abstract

The optimal approach to stem cell transplantation in children with immunodeficiency who lack a matched family donor is controversial. Unrelated donor stem cell transplantation gives equivalent outcome to mismatched family donor stem cell transplantation in severe combined immunodeficiency, whereas unrelated donors may be preferable in non-severe combined immunodeficiency children. However, unrelated donor stem cell transplantation with conventional conditioning regimens has been associated with significant treatment-related toxicity, particularly in non-severe combined immunodeficiency patients with preexisting organ dysfunction. We report the outcome of a series of 33 consecutive unrelated donor transplantations performed at our center in children with primary immunodeficiency using a reduced-intensity conditioning regimen between 1998 and 2001. We have compared these outcomes with a retrospective control cohort of 19 patients who underwent transplantation with myeloablative conditioning between 1994 and 1998. All children in both groups had primary engraftment. There was no statistical difference in the speed of immune reconstitution or incidence of graft-versus-host disease between the 2 groups. Overall survival was signific...Continue Reading

References

Mar 1, 1997·The Journal of Pediatrics·W M Comans-BitterJ J van Dongen
Feb 18, 1999·The New England Journal of Medicine·R H BuckleyF E Ward
Jul 15, 2004·Transplantation Proceedings·S ChakrabartiH Waldmann
Jun 3, 2005·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Claude SportèsRonald E Gress

❮ Previous
Next ❯

Citations

Oct 29, 2013·Lancet·Tayfun GüngörUNKNOWN Inborn Errors Working Party of the European Society for Blood and Marrow Transplantation
Sep 25, 2008·Bone Marrow Transplantation·Ah Filipovich
Jul 24, 2008·Bone Marrow Transplantation·I YanivUNKNOWN EBMT Paediatric Working Party
Oct 31, 2007·Bone Marrow Transplantation·C C Dvorak, M J Cowan
Dec 18, 2007·Bone Marrow Transplantation·C Díaz de HerediaJ Sánchez de Toledo
Jun 14, 2006·Transplantation·W Scott GoebelPaul R Haut
Oct 10, 2013·Current Opinion in Hematology·Austen J J WorthPaul Veys
Jun 6, 2007·The Journal of Clinical Investigation·Marina Cavazzana-Calvo, Alain Fischer
Aug 7, 2007·International Journal of Hematology·Masahiro TokunagaYoshihisa Kodera
Dec 3, 2014·Hematology/oncology Clinics of North America·Elizabeth Kang, Andrew Gennery
Jul 15, 2015·Expert Review of Clinical Immunology·Austen J J Worth, Adrian J Thrasher
Mar 7, 2012·Expert Review of Clinical Immunology·Robert Chiesa, Paul Veys
Aug 27, 2005·Expert Opinion on Biological Therapy·H Bobby Gaspar, Adrian J Thrasher
Oct 22, 2013·The Journal of Allergy and Clinical Immunology·Linda M GriffithUNKNOWN workshop participants
Jan 18, 2011·Hematology/oncology Clinics of North America·M Teresa de la Morena, Richard A Gatti
Jan 18, 2011·Hematology/oncology Clinics of North America·Eyal Grunebaum, Chaim M Roifman
May 25, 2010·Immunology and Allergy Clinics of North America·Sung-Yun Pai, Luigi D Notarangelo
Mar 24, 2010·Pediatric Clinics of North America·Paul SzabolcsPaul Veys
Feb 2, 2010·Immunology and Allergy Clinics of North America·M Teresa de la Morena, Richard A Gatti
Feb 2, 2010·Immunology and Allergy Clinics of North America·Paul Veys
Feb 2, 2010·Immunology and Allergy Clinics of North America·Christopher C Dvorak, Morton J Cowan
Feb 2, 2010·Immunology and Allergy Clinics of North America·Eyal Grunebaum, Chaim M Roifman
Jan 30, 2010·Seminars in Hematology·Angela R SmithK Scott Baker
Nov 11, 2008·The Journal of Allergy and Clinical Immunology·Linda M GriffithWilliam T Shearer
Apr 22, 2008·Immunology and Allergy Clinics of North America·Andrew R Gennery, Andrew J Cant

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.